20-63346761-G-T
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP6BS1BS2
The ENST00000370263.9(CHRNA4):c.1861C>A(p.Pro621Thr) variant causes a missense change. The variant allele was found at a frequency of 0.0000242 in 1,611,284 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P621S) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000370263.9 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -9 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CHRNA4 | NM_000744.7 | c.1861C>A | p.Pro621Thr | missense_variant | 6/6 | ENST00000370263.9 | NP_000735.1 | |
CHRNA4 | NM_001256573.2 | c.1333C>A | p.Pro445Thr | missense_variant | 6/6 | NP_001243502.1 | ||
CHRNA4 | NR_046317.2 | n.2070C>A | non_coding_transcript_exon_variant | 6/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CHRNA4 | ENST00000370263.9 | c.1861C>A | p.Pro621Thr | missense_variant | 6/6 | 1 | NM_000744.7 | ENSP00000359285 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000985 AC: 15AN: 152220Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000244 AC: 6AN: 245578Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133702
GnomAD4 exome AF: 0.0000165 AC: 24AN: 1458946Hom.: 0 Cov.: 32 AF XY: 0.0000124 AC XY: 9AN XY: 725890
GnomAD4 genome AF: 0.0000985 AC: 15AN: 152338Hom.: 0 Cov.: 33 AF XY: 0.000134 AC XY: 10AN XY: 74492
ClinVar
Submissions by phenotype
Autosomal dominant nocturnal frontal lobe epilepsy 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 24, 2021 | - - |
Autosomal dominant nocturnal frontal lobe epilepsy Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 06, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 22, 2020 | In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at